Arbutus Biopharma Corporation share price logo

Arbutus Biopharma Corporation Share Price

NASDAQ: ABUS

Small Cap

$4.53

+0.07

(+1.57%)

as on

Arbutus Biopharma Corporation Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.37
    $4.57
    downward going graph

    3.53%

    Downside

    0.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.71
    $5.1
    downward going graph

    40.29%

    Downside

    12.58%

    Upside

    downward going graph

Arbutus Biopharma Corporation share price movements today

Previous Close
$4.46
Open
$4.54
Volume
973.9K
Day's Low - High
$4.37 - $4.57
52 Week Low - High
$2.71 - $5.1

Arbutus Biopharma Corporation Historical Returns

1 Month Return
+ 32.54 %
3 Month Return
+ 26.35 %
1 Year Return
-0.22 %
3 Year Return
+ 93.07 %
5 Year Return
+ 51.7 %

Arbutus Biopharma Corporation Stock Fundamentals & Key Indicators

Check Arbutus Biopharma Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$855.0M

EPS (TTM)

-0.253

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.38

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-43.2M

Revenue (TTM)

15.4M

Profit Margin

0.00%

Return On Equity TTM

6397900.00%

Arbutus Biopharma Corporation Stock Valuation

Track how Arbutus Biopharma Corporation P/E has moved over time to understand its valuation trends.

Arbutus Biopharma Corporation in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-9.38x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -9.38x

Arbutus Biopharma Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arbutus Biopharma Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$855.0M51.7%-9.380.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Arbutus Biopharma Corporation Stock including INR - Dollar returns

The Arbutus Biopharma Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arbutus Biopharma Corporation investment value today

Current value as on today

₹1,06,328

Returns

₹6,328

(+6.33%)

Returns from Arbutus Biopharma Corporation Stock

₹1,342 (+1.34%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Arbutus Biopharma Corporation Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Arbutus Biopharma Corporation. Average target price of $5.23

Arbutus Biopharma Corporation Share Price Target

Get share price movements and forecasts by analysts on Arbutus Biopharma Corporation.

What analysts predicted

13.38%UPSIDE

Target Price

$5.23

Current Price

$4.53

Analyzed by

11 Analysts

Target

$5.23

Arbutus Biopharma Corporation target price $5.23, a slight upside of 13.38% compared to current price of $4.53. According to 11 analysts rating.

Arbutus Biopharma Corporation Stock's Interest Amongst Investors

Search interest for Arbutus Biopharma Corporation Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Arbutus Biopharma Corporation Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
6
4
4
2
1
1
1
1
1
10
Gross Profit
6
4
4
1
1
1
1
1
-7
10
Operating Income
-17
-18
-21
-20
-19
-21
-21
-13
-34
1
EBITDA
-15
-16
-19
-18
-17
-19
-19
-12
-24
2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-17
-20
-19
-17
-19
-19
-12
-24
2
Income Tax Expense
0
0
0
1
0
0
-
-
-
-
Net Income
-15
-17
-20
-19
-17
-19
-19
-12
-24
2
Net Profit Margin
-231.24%
-367.53%
-431.60%
-900.33%
-1166.78%
-1146.93%
-1472.52%
-796.19%
-1390.36%
23.49%

Arbutus Biopharma Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
24
1
10
5
6
6
10
39
18
6
Gross Profit
-26
-59
-52
-52
-51
-40
9
37
-55
4
Operating Income
-102
-491
-110
-89
-144
-57
-73
-65
-78
-76
EBITDA
-76
-488
-106
-58
-147
-57
-71
-61
-70
-68
Interest Expense
0
1
0
0
2
4
2
1
0
0
Depreciation
-
-
2
2
2
1
1
1
1
1
Income Before Tax
-77
-489
-108
-61
-166
-63
-76
-65
-72
-69
Income Tax Expense
-16
-105
-24
-4
-12
1
1
4
0
-
Net Income
-61
-384
-84
-57
-153
-65
-77
-69
-72
-69
Net Profit Margin
-245.73%
-25606.67%
-788.79%
-967.80%
-2557.36%
-943.17%
-703.96%
-178.01%
-401.57%
-1133.04%

Arbutus Biopharma Corporation Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-17
-20
-19
-17
-19
-19
-12
-24
2
Operating Cash Flow
-19
-21
-16
-19
-14
-20
-10
-13
-15
Investing Cash Flow
1
10
21
11
9
-11
13
11
15
Financing Cash Flow
4
1
3
24
24
1
1
2
0
Change in Cash
-13
-9
8
16
19
-30
4
0
0

Arbutus Biopharma Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-384
-84
-57
-153
-63
-76
-69
-72
-69
Operating Cash Flow
-57
-48
-67
-71
-51
-67
-35
-85
-64
Investing Cash Flow
-99
27
-4
28
-14
-12
-74
50
22
Financing Cash Flow
12
49
55
37
86
137
31
30
51
Change in Cash
-143
30
-17
-5
20
57
-78
-4
10

Global Institutional Holdings in Arbutus Biopharma Corporation

Funds
Holdings
Morgan Stanley - Brokerage Accounts
12.41%
Whitefort Capital Management, LP.
6.94%
BlackRock Inc
6.66%
Two Seas Capital LP
4.94%
Vanguard Group Inc
4.67%

Insights on Arbutus Biopharma Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ABUS stock has moved up by 34.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.33M → 10.73M (in $), with an average increase of 36.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.52M → 2.52M (in $), with an average increase of 1072.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 12.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 64.3%

About Arbutus Biopharma Corporation

arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease. in addition to our hbv assets, we are developing a pipeline of programs that leverage our expertise in rna interference (rnai) therapeutics and our lipid nanoparticle (lnp) technology.
OrganisationArbutus Biopharma Corporation
Headquarters701 Veterans Circle, Warminster, PA, United States, 18974
IndustryHealth Technology
CEOMs. Lindsay Androski J.D., M.B.A.
E-voting on sharesClick here to vote

Key Management of Arbutus Biopharma Corporation

Name

Title

Ms. Lindsay Androski J.D., M.B.A.

President, CEO & Chairman

Mr. Tuan Nguyen

Chief Financial Officer

Mr. Andrew J. Sung

General Counsel

Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C.

Corporate Secretary

FAQs

What is Arbutus Biopharma Corporation share price today?

Arbutus Biopharma Corporation share price today is $4.53 as on at the close of the market. Arbutus Biopharma Corporation share today touched a day high of $4.57 and a low of $4.37.

What is the 52 week high and 52 week low for Arbutus Biopharma Corporation share?

Arbutus Biopharma Corporation share touched a 52 week high of $5.1 on and a 52 week low of $2.71 on . Arbutus Biopharma Corporation stock price today i.e. is closed at $4.53,which is 11.18% down from its 52 week high and 67.47% up from its 52 week low.

What is Arbutus Biopharma Corporation's market capitalisation today?

Arbutus Biopharma Corporation market capitalisation is $0.00T as on .

How to invest in Arbutus Biopharma Corporation Stock (ABUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arbutus Biopharma Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arbutus Biopharma Corporation Shares that will get you 0.3311 shares as per Arbutus Biopharma Corporation share price of $4.53 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Arbutus Biopharma Corporation Stock (ABUS) from India?

Indian investors can start investing in Arbutus Biopharma Corporation (ABUS) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Arbutus Biopharma Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Arbutus Biopharma Corporation share’s latest price of $4.53 as on September 16, 2025 at 1:29 am IST, you will get 2.2075 shares of Arbutus Biopharma Corporation. Learn more about fractional shares .

What are the returns that Arbutus Biopharma Corporation has given to Indian investors in the last 5 years?

Arbutus Biopharma Corporation stock has given 51.7% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?